Denglong Wu
Impact in
- Cancer Research top 5%
- MicroRNA in disease regulation
- Cancer-related molecular mechanisms research
- Urology top 2%
- Urinary Bladder and Prostate Research
Papers in
-
- Ubiquitin and proteasome pathways 10
- Circular RNAs in diseases 8
- Protein Degradation and Inhibitors 7
-
- Prostate Cancer Treatment and Research 27
- Co-authors
- Shengsong Huang (38 shared papers)Gang Wu (10 shared papers)Chengdang Xu (23 shared papers)Zhendong Xiang (8 shared papers)Junliang Li (5 shared papers)Qiang Wu (4 shared papers)Jinfu Zhang (4 shared papers)Zhong Wu (2 shared papers)
- Journals
- The Journal of Urology (3 papers)Cell Death and Disease (3 papers)Frontiers in Oncology (3 papers)Cell Death Discovery (2 papers)Photoacoustics (2 papers)
- Partner nations
- ChinaUnited StatesTaiwan
In The Last Decade
Denglong Wu
82 papers receiving 1.5k citations
Peers
Comparison fields: 5 of 102
- Cancer Research 497
- Urology 152
- Molecular Biology 805
- Pulmonary and Respiratory Medicine 312
- Rheumatology 126
Countries citing papers authored by Denglong Wu
This map shows the geographic impact of Denglong Wu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Denglong Wu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Denglong Wu more than expected).
Fields of papers citing papers by Denglong Wu
This network shows the impact of papers produced by Denglong Wu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Denglong Wu. The network helps show where Denglong Wu may publish in the future.
Co-authors
The 25 scholars most cited alongside Denglong Wu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 87 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2015 | 104 | |
| 2 | 2019 | 77 | |
| 3 | 2004 | 64 | |
| 4 | 2015 | 57 | |
| 5 | 2004 | 54 | |
| 6 | MiRNA-125b inhibits proliferation and migration by targeting SphK1 in bladder cancer. | 2015 | 53 |
| 7 | 2019 | 51 | |
| 8 | Prevalence and risk factors of urinary incontinence among Chinese women in Shanghai. | 2014 | 50 |
| 9 | MiRNA-29c regulates cell growth and invasion by targeting CDK6 in bladder cancer. | 2015 | 50 |
| 10 | 2018 | 41 | |
| 11 | MiR-29a suppresses prostate cell proliferation and induces apoptosis via KDM5B protein regulation. | 2015 | 41 |
| 12 | 2015 | 38 | |
| 13 | 2016 | 36 | |
| 14 | 2020 | 31 | |
| 15 | 2016 | 31 | |
| 16 | 2004 | 29 | |
| 17 | 2019 | 27 | |
| 18 | 2015 | 26 | |
| 19 | 2011 | 25 | |
| 20 | 2012 | 24 |
About Denglong Wu
Denglong Wu is a scholar working on Molecular Biology, Pulmonary and Respiratory Medicine, Cancer Research, Surgery and Urology, having authored 87 papers that have together received 1.5k indexed citations. Recurring topics across this work include Prostate Cancer Treatment and Research (27 papers), Cancer-related molecular mechanisms research (14 papers), Urological Disorders and Treatments (10 papers), Ubiquitin and proteasome pathways (10 papers), Cancer, Lipids, and Metabolism (8 papers), Circular RNAs in diseases (8 papers), Protein Degradation and Inhibitors (7 papers) and Urinary and Genital Oncology Studies (7 papers). The work is most often cited by research in Cancer Research (497 citations), Urology (152 citations), Molecular Biology (805 citations), Pulmonary and Respiratory Medicine (312 citations) and Rheumatology (126 citations). Denglong Wu has collaborated with scholars based in China, United States and Taiwan. Frequent co-authors include Shengsong Huang, Gang Wu, Chengdang Xu, Zhendong Xiang, Junliang Li, Qiang Wu, Jinfu Zhang, Zhong Wu, Ming Guan and Yuan Lu. Their work appears in journals such as The Journal of Urology, Cell Death and Disease, Frontiers in Oncology, Cell Death Discovery and Photoacoustics.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.